Fundz

Genesis Therapeutics reported raising $224 Million in an initial SEC Form D filing, from an offering of $224 Million

PRIVATEAug 25, 2023

Amount Raised

$224 Million

$224 Million sold, per SEC Form D (first sale Aug 10, 2023)

Round Type

Venture

BurlingameBiotechnology

Quick answer

Genesis Therapeutics, Inc. raised $224 Million in a funding round, dated August 10, 2023. Genesis Therapeutics, Inc. is based in Burlingame, California, United States.

How much did Genesis Therapeutics, Inc. raise?
Genesis Therapeutics, Inc. raised $224 Million in a funding round on August 10, 2023.
What does Genesis Therapeutics, Inc. do?
Genesis Therapeutics – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego – is unifying AI and biotechnology to discover novel and breakthrough treatments for patients with severe and..
Where is Genesis Therapeutics, Inc. based and how big is it?
Genesis Therapeutics, Inc. is based in Burlingame, California, United States.
Who are the decision-makers at Genesis Therapeutics, Inc?
Fundz holds 2 contacts at Genesis Therapeutics, Inc., including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Genesis Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Qihan Biotech raised an undisclosed amount (Series B) on September 23, 2023.
  • Avalyn raised $189M on September 22, 2023.
  • CMR Surgical raised $165M (Funding Round) on September 22, 2023.
  • ENB Therapeutics, Inc. raised $225K (Seed) on September 22, 2023.
  • Elutia raised $11M on September 21, 2023.
  • CMR Surgical raised $165M (Funding Round) on September 21, 2023.

Who to call at Genesis Therapeutics, Inc., and when

A new round usually means Genesis Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Genesis Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Genesis Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Genesis Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Genesis Therapeutics, Inc.

Location

1860 EL CAMINO REAL

Burlingame, California, United States

About

Genesis Therapeutics – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego – is unifying AI and biotechnology to discover novel and breakthrough treatments for patients with severe and devastating conditions. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Genesis Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsEvan F., Executive Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Genesis Therapeutics, Inc.'s next move

See what Strategic adds

Genesis Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.